Response to 'Neither earlier not late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study' by Moiseev et al

Ann Rheum Dis. 2023 Jan;82(1):e4. doi: 10.1136/annrheumdis-2020-219295. Epub 2020 Oct 30.

Sofia Ramiro^{1

2}, Robert B M Landewé^{3

4}, Rémy Mostard⁵

¹ Department of Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, Limburg, The Netherlands sofiaramiro@gmail.com.
² Department of Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
³ Department of Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, Limburg, The Netherlands.
⁴ Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands.
⁵ Department of Pulmonology, Zuyderland Medical Center, Heerlen, The Netherlands.

No abstract available

Keywords: epidemiology; health care; immune complex diseases; outcome assessment.

Publication types